CytoDyn Inc.
CYDY
$0.2926
-$0.0034-1.15%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.96M | -4.76M | -4.77M | 19.23M | -16.79M |
| Total Depreciation and Amortization | 4.00K | 5.00K | 4.00K | 5.00K | 4.00K |
| Total Amortization of Deferred Charges | 59.00K | 110.00K | 113.00K | 125.00K | 125.00K |
| Total Other Non-Cash Items | 599.00K | 13.00K | 457.00K | 2.17M | 9.67M |
| Change in Net Operating Assets | -369.00K | -326.00K | 608.00K | -16.09M | 5.34M |
| Cash from Operations | -5.66M | -4.96M | -3.59M | 5.44M | -1.65M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -710.00K | -- |
| Issuance of Common Stock | 1.17M | 21.00K | -- | -- | 3.44M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 10.38M | -- |
| Cash from Financing | 1.17M | 21.00K | 0.00 | 9.67M | 3.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.50M | -4.94M | -3.59M | 15.11M | 1.79M |